跳至主要内容
临床试验/NCT02229097
NCT02229097已完成4 期

Clinical Efficacy of Coordinated Boluses in Type 1 Diabetic Patients Treated With Insulin Pumps: a Multicentric, Randomised, Cross Over Study

University Hospital, Toulouse3 个研究点 分布在 1 个国家目标入组 17 人开始时间: 2014年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
17
试验地点
3
主要终点
postprandial glycaemia

研究概览

简要总结

A recent study suggests that, in Type 1 Diabetes (T1D) patients treated by insulin pumps, a better coordination of meal boluses and post prandial basal rate could reduce the importance of postprandial hyperglycaemias without increasing the risk of delayed hypoglycaemias.

The aim of the investigators study is to assess if these results are confirmed in a clinical trial.

The aim of this study is to compare the efficacy of coordinated boluses versus normal boluses on postprandial glycaemic control of T1D patients treated with continuous subcutaneous insulin infusion.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Type 1 diabetes mellitus
  • with confirmed Negative C-peptide or diabetes duration>5 years
  • Treated by external insulin pump and rapid insulin analog for more than 3 months
  • using a Medtronic Paradigm Real-Time or Veo™ model
  • Educated to and practicing functional insulin treatment and carbohydrate counting for more than 3 months
  • Able to use the "basal temp" and "glycaemia reminder" functions of their pump
  • Basal infusion rate ≥ 0,5 Unit/h
  • Self-monitoring of blood glucose frequency > 4/days
  • Aware of hypoglycaemia

排除标准

  • known impaired renal function (creatinin clearance <60ml/min)
  • Gastroparesis
  • Serious or instable disease likely to induce a glycaemic control deterioration - treatment with corticosteroids

研究组 & 干预措施

Normal then Coordinated

Experimental

normal bolus during 2 weeks then coordinated bolus during 2 weeks

干预措施: Normal bolus (Drug)

Normal then Coordinated

Experimental

normal bolus during 2 weeks then coordinated bolus during 2 weeks

干预措施: Coordinated bolus (Drug)

Coordinated then Normal

Experimental

coordinated bolus during 2 weeks then normal bolus during 2 weeks

干预措施: Normal bolus (Drug)

Coordinated then Normal

Experimental

coordinated bolus during 2 weeks then normal bolus during 2 weeks

干预措施: Coordinated bolus (Drug)

结局指标

主要结局

postprandial glycaemia

时间窗: 2 hours after eating during 4 weeks

measured by Self Monitoring of Blood Glucose

次要结局

  • mean glycaemia(before eating and 2 hours after eating during 4 weeks)
  • adverse events(Throughout the study (4 weeks))
  • severe hypoglycaemia frequency(Throughout the study (4 weeks))
  • frequency of glycaemia < or = 60mg/dl(before eating and 2 hours after eating during 4 weeks)
  • insulin doses(basal rate and boluses)
  • frequency of glycaemia between 61-140mg/dl(before eating and 2 hours after eating during 4 weeks)
  • standard deviation of glycaemia(before eating and 2 hours after eating during 4 weeks)
  • frequency of glycaemia >140mg/dl(before eating and 2 hours after eating during 4 weeks)
  • mean glycemia(Throughout the day during 4 weeks)
  • standard deviation(Throughout the day during 4 weeks)
  • time spent within glucose range < or = 60mg/dl(Throughout the day during 4 weeks)
  • time spent within glucose range between 61-140mg/dl(Throughout the day during 4 weeks)
  • time spent within glucose range mg/dl(Throughout the day during 4 weeks)
  • fructosamine(day 1 + 4 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验